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S epsis and septic shock are the most common causes of death in intensive care units worldwide 
[1] and frequently lead to multiple organ failure.  The 
liver is a major target organ [2],  and up to 50% of 
patients with sepsis experience liver involvement [3].  
We previously demonstrated that expression of heme 
oxygenase-1 (HO-1),  the rate-limiting enzyme in heme 
catabolism,  is upregulated,  and expression of δ-amino-
levulinate synthase (ALAS1),  the rate-limiting enzyme 
in heme biosynthesis,  is downregulated in the rat liver 
following intraperitoneal administration of lipopoly-
saccharide (LPS) [4].  This suggests that free heme 
released from hepatic heme proteins enhances oxidative 
stress and exacerbates hepatic injury in septic liver 
damage.  
The heme-responsive transcription factor BTB and 
CNC homology 1 (Bach1) represses HO-1 expression 
under normal conditions (baseline conditions),  but is 
exported from the nucleus to allow for transcriptional 
activation of HO-1 in the presence of excess free heme 
[5-7].  Reactive oxygen species and free heme,  a 
pro-oxidant,  are thought to be involved in the patho-
genesis of septic multiple organ failure and LPS-
induced tissue injury [8 , 9].  However,  the mechanisms 
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Hepatic oxidative stress plays an important role in the pathogenesis of several acute liver diseases,  and free 
heme is thought to contribute to endotoxemia-induced acute liver injury.  The heme oxygenase 1 (HO-1) gene is 
upregulated and the δ-aminolevulinate synthase (ALAS1) gene is downregulated in the rat liver following lipo-
polysaccharide (LPS) treatment.  BTB and CNC homology 1 (Bach1) is a heme-responsive transcription factor 
that normally represses HO-1 expression.  In this study,  we evaluated the changes in HO-1,  ALAS1,  and Bach1 
expression and nuclear Bach1 expression in rat livers following intravenous LPS administration (10 mg/kg body 
weight).  LPS significantly upregulated HO-1 mRNA and downregulated ALAS1 mRNA in the rat livers,  suggest-
ing that hepatic free heme concentrations are increased after LPS treatment.  Bach1 mRNA was strongly induced 
after LPS injection.  In contrast,  nuclear Bach1 was significantly but transiently decreased after LPS treatment.  
Rats were also administered hemin (50 mg/kg body weight) intravenously to elevate heme concentrations,  
which decreased nuclear Bach1 levels.  Our results suggest that elevated hepatic free heme may be associated 
with a decline of nuclear Bach1,  and induction of Bach1 mRNA may compensate for the decreased nuclear 
Bach1 after LPS treatment in the rat liver.
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underlying these effects are not fully understood.
In this study,  we evaluated the changes in gene and 
nuclear protein expression of Bach1 over time after 
intravenous LPS treatment in association with heme 
metabolism.
Materials and Methods
Materials. LPS from Escherichia coli O127:B8 was 
purchased from Sigma-Aldrich (St. Louis,  MO,  USA).  
Hemin (BioXtra,  from pigs) was also purchased from 
Sigma-Aldrich.  Rabbit anti-BACH1 polyclonal anti-
bodies (cat.  no. 14018-1-AP) and mouse beta-actin 
monoclonal antibodies (cat.  no. sc-47778) were pur-
chased from Proteintech (Rosemont,  IL,  USA) and 
Santa Cruz Biotechnology (Dallas,  TX,  USA),  respec-
tively.  Horseradish peroxidase-conjugated goat 
anti-rabbit IgG (cat.  no. sc-2004) and horseradish per-
oxidase-conjugated goat anti-mouse IgG (cat.  
no. sc-2005) were purchased from Santa Cruz 
Biotechnology.
Animal experiments. All animal experiments 
were approved by the Animal Use and Care Committee 
of Okayama University Medical School (Okayama,  
Japan; approval nos.  OKU-2014409,  OKU-2014528 
and OKU-2020546).  The care and handling of the ani-
mals were carried out in accordance with the National 
Institutes of Health Guidelines for Animal Research 
(Guide for the Care and Use of Laboratory Animals).
Male Sprague-Dawley rats,  weighing 200-250 g,  
were purchased from CLEA Japan,  Inc.  (Tokyo).  The 
rats were housed in a temperature-controlled (25°C) 
room with a 12-h light/dark cycle and allowed free 
access to water and chow diet for at least 6-7 days until 
the start of experiments.  All surgical procedures and 
painful treatments were carried out under anesthesia 
with ethyl ether.
Experimental protocols and treatments. The rats 
were randomly divided into the following 4 groups:  
LPS-treated animals,  saline-treated animals,  untreated 
control animals,  and hemin-treated animals.  The LPS-
treated animals were administered LPS (10 mg/kg body 
weight) intravenously (i.v.) via the tail vein to develop 
an in vivo endotoxemia model.  LPS was dissolved in 
sterile saline to give a final concentration of 10 mg/ml.  
Saline-treated control animals were administered the 
same volume of physiological saline (1 ml/kg body 
weight).  In another set of experiments,  hemin-treated 
animals were administered hemin (ferriprotoporphyrin 
IX chloride; 50 mg/kg body weight,  i.v.) to elevate free 
heme concentrations in liver tissue.  Hemin was dis-
solved in a small volume of 0.1 M NaOH solution and 
reconstituted in physiological saline.  The pH was then 
adjusted to 7.4 with 0.1 M HCl solution to yield a final 
concentration of 50 mg/ml.
After treatment,  the animals were returned to the 
cages and allowed free access to food and water.  Under 
light anesthesia with ethyl ether,  the animals were sac-
rificed by bleeding through a catheter in the abdominal 
aorta at defined time points (0-48 h).  Blood was col-
lected for serum isolation to measure serum aspartate 
aminotransferase (AST) and alanine aminotransferase 
(ALT) activities,  and the livers were excised,  immedi-
ately frozen in liquid nitrogen,  and stored at −80°C 
until the preparation of RNA and nuclear protein 
extracts.  Liver samples were used for hematoxylin and 
eosin staining of liver tissue sections and assessment of 
hepatic gene and protein expression.  Hepatic mRNA 
levels were examined by northern blot analysis.  Hepatic 
protein levels were examined by western blot analysis.  
Histological examination. For histological 
examination,  liver tissue was fixed in 10% neutral-buff-
ered formalin,  embedded in paraffin,  and sectioned at 
4-6 µm thickness.  After deparaffinization and dehydra-
tion,  the sections were stained with hematoxylin and 
eosin for microscopic examination.  
Measurement of serum AST and ALT activities.
Serum was separated from whole blood by centrifuga-
tion at 1,600 × g for 10 min at 4°C,  and serum AST and 
ALT activities were measured using an automated clin-
ical chemistry analyzer (FUJI DRI-CHEM 7000i; FU-
JIFILM Corporation,  Tokyo).
cDNA probes. The template cDNAs used to gener-
ate probes for northern blot analysis included rat pRHO-1 
[10],  provided by Dr. S.  Shibahara; rat pKRA2cA [11] 
and ALAS1,  provided by Dr. M.  Yamamoto; and rat 
Bach1 cDNA,  corresponding to base pairs 785-1382,  
provided by Dr. K.  Igarashi (Tohoku University,  Sendai,  
Japan).  All cDNA probes used for northern blot analy-
sis were labeled with [α-32P] dCTP (PerkinElmer,  
Waltham,  MA,  USA) using High Prime premixed 
solution (Roche Applied Science,  Mannheim,  Germany) 
according to the manufacturer’s instructions.
RNA isolation and northern blot analysis. Total 
RNA was isolated from rat tissues using TRI-Reagent 
(Sigma-Aldrich) according to the manufacturer’s 
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instructions.  Northern blot analysis was performed as 
previously described [12].  Briefly,  total RNA (20 µg) 
was separated by electrophoresis on 1.2% (w/v) agarose 
gels containing 6.5% (v/v) formaldehyde.  After blotting 
on a sheet of Bio-Rad Zeta-Probe GT blotting mem-
brane (Bio-Rad Laboratories,  Hercules,  CA,  USA),  the 
RNA samples were hybridized with the [α-32P] 
dCTP-labeled cDNA probes,  followed by washing 
under stringent conditions.  Each blotted membrane 
was exposed to a sheet of Fuji Medical X-ray film 
(FUJIFILM Corporation) with an intensifying screen at 
−80°C.  Target bands and the 18S ribosomal RNA band 
on autoradiographs were quantified using a ChemiDoc 
XRS Plus Imaging System and Image Lab Software ver-
sion 5.0 (Bio-Rad Laboratories).  The relative amounts 
of hybridized radiolabeled cDNAs were normalized to 
18S ribosomal RNA levels to correct for differences in 
gel loading.
Preparation of nuclear protein extracts and western 
blot analysis. Nuclear protein was isolated from the 
rat tissues using NE-PER Nuclear and Cytoplasmic 
Extraction Reagents (Thermo Fisher Scientific,  Waltham,  
MA,  USA) according to the manufacturer’s instructions.  
Protein concentrations were determined using a Pierce 
BCA Protein Assay Kit (Thermo Fisher Scientific).  
Samples equivalent to 25 µg protein were treated with 
premixed sample buffer (4 ×  Laemmli sample buffer;  
Bio-Rad Laboratories) and applied to 12.5% or 7.5% (w/
v) polyacrylamide gels (ATTO Corporation,  Tokyo).  
After electrophoretic separation based on the method of 
Laemmli,  proteins were transferred to Amersham 
Hybond-P polyvinylidene fluoride membranes (GE 
Healthcare,  Little Chalfont,  UK).  The membranes were 
then blocked with Block Ace Powder (DS Pharma 
Biomedical Co.,  Ltd.  Osaka,  Japan) at room tempera-
ture for 1 h,  followed by incubation with rabbit anti-
BACH1 polyclonal antibodies diluted at 1 : 1000 with 
Tris-buffered saline (TBS) containing 0.1% Tween-20 
(TBS-T) at 4°C overnight.  The membranes were then 
treated with horseradish peroxidase-conjugated goat 
anti-rabbit IgG diluted at 1 : 20,000 with TBS-T at room 
temperature for 1 h.  Antigen/antibody complexes were 
incubated with Clarity Western ECL Blotting Substrate 
(Bio-Rad Laboratories).  The obtained chemilumines-
cent signals were detected and quantified using a 
ChemiDoc XRS Plus Imaging System and Image Lab 
Software version 5.0 (Bio-Rad Laboratories).  The trans-
fer efficiency and an equal amount of loading per lane 
were verified by quantifying the chemiluminescent sig-
nals of β-actin obtained from the same protein samples 
after incubating the membranes with mouse beta-actin 
monoclonal antibodies diluted at 1 : 5000 with TBS-T at 
4°C overnight,  followed by treatment with horseradish 
peroxidase-conjugated goat anti-mouse IgG diluted at 
1: 20, 000 with TBS-T at room temperature for 1 h.
Determination of the heme concentration in micro-
somes. Liver samples were also used for assessment 
of the heme concentration in the hepatic microsomal 
fraction.  Livers were homogenized in 3 volumes of 
1.15% KCl (w/v) and centrifuged at 10,000 × g for 
30 min at 4°C,  followed by a 104,000 × g centrifugation 
of the supernatant for 60 min at 4°C to obtain the mic-
rosomal fraction.  The pellet was resuspended in 0.1 M 
potassium phosphate buffer (pH 7.4) containing 10% 
glycerol and used for the measurement of the heme 
concentration by the pyridine hemochromogen method 
[13 , 14],  using a spectrophotometer (Ubest-55; JASCO 
Corporation,  Tokyo).  The heme concentration was 
expressed as nanomoles per milligram of protein.  
Protein concentrations of the hepatic microsomal frac-
tion were determined using a Pierce BCA Protein Assay 
Kit (Thermo Fisher Scientific).  The absorbance was 
measured using a microplate reader (VICTOR Nivo 
Multimode Plate Reader; PerkinElmer).
Statistical analysis. For statistical evaluation,  
multiple group comparisons were performed by analysis 
of variance,  followed by Bonferroni correction post-hoc 
tests.  Differences with p values of less than 0.05 were 
considered statistically significant.  
Results
Effects of LPS treatment on serum AST and ALT 
levels. Serum AST and ALT levels were assessed as a 
measure of LPS-induced hepatic dysfunction.  Serum 
levels of AST and ALT increased sharply immediately 
after intravenous injection of LPS (10 mg/kg),  followed 
by a more gradual increase,  and were significantly ele-
vated by 6 h after LPS treatment compared to the levels 
in the untreated and vehicle-treated control groups 
(Fig. 1).  The serum AST and ALT levels then remained 
at high levels until 24 h after LPS treatment (Fig. 1).  The 
marked elevation in these hepatic enzymes indicated 
the occurrence of LPS-induced hepatic injury.
Effects of LPS treatment on histological findings.
We examined histological changes in the hematoxylin 
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and eosin-stained sections of rat livers to confirm LPS-
induced hepatic injury.  Sections of livers excised from 
untreated control and vehicle-treated control rats had a 
normal histological appearance (Fig. 2A and B),  
whereas sections excised from LPS-treated rats at 24 h 
after injection revealed massive and severe hepatic 
necrosis in the centrilobular zone with hemorrhage 
(Fig. 2C).  These results indicate that i.v.  injection of 
LPS caused endotoxemia-induced liver injury in the rat 
model.
Effects of LPS treatment on HO‑1 and ALAS1 
expression. We confirmed that HO-1 and ALAS1 
expression was altered after i.v.  LPS treatment.  HO-1 
mRNA expression was very low in the untreated and 
vehicle-treated control livers (Fig. 3A and B).  However,  










Fig. 2　 Histological changes in rat livers after LPS treatment.  
The rats were injected i.v.  with LPS (10 mg/kg) or saline (1 ml/kg) 
and were sacrificed at 24 h after injection.  Livers were removed for 
histological examination of hematoxylin and eosin-stained liver sec-
tions.  Representative light microscopic images of livers from at 
least three independent experiments are shown.  P and C denote 
the portal tract and central vein,  respectively.  The bar represents 
100 μm.  (A),  Livers in the untreated control group showed normal 
liver histology; (B),  Livers in the vehicle-treated control group,  at 
24 h after injection of saline,  showed almost normal histology; (C),  
Livers in the LPS group,  at 24 h after injection of LPS,  showed 
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Fig. 1　 Effects of LPS treatment on serum AST and ALT activi-
ties.  The rats were injected i.v.  with LPS (10 mg/kg) or saline 
(1 ml/kg) and were sacrificed at 0,  1,  3,  6,  12,  or 24 h after treat-
ment.  Whole blood was collected for measurement of serum AST 
and ALT activities.  Data are expressed as the means±standard 
deviations (n=6-10) and were statistically evaluated using ANOVA 
followed by Bonferroni correction post-hoc tests.  ＊P<0.05 versus 
the untreated control group (LPS 0 h).  NS 6 h,  vehicle-treated con-
trol group; LPS,  lipopolysaccharide; AST,  aspartate aminotrans-
ferase; ALT,  alanine aminotransferase.
the HO-1 mRNA levels began increasing at 1-3 h after 
LPS injection,  reaching a maximum level 7-fold higher 
than that in untreated control livers at 6 h after treat-
ment prior to a gradual decrease to less than 50% of the 
maximum by 48 h (Fig. 3A and B).  In contrast,  ALAS1 
mRNA was highly expressed in the untreated and vehi-
cle-treated control livers (Fig. 3C and D).  Following i.v.  
LPS injection,  the levels of hepatic ALAS1 mRNA were 
slightly increased just after treatment but decreased to a 
minimum of 60% of baseline by 3 h,  followed by a rapid 
increase and return to a level above the baseline by 6 h 
after treatment,  which was maintained throughout the 
observation period (Fig. 3C and D).  These changes were 
consistent with those reported in our previous study [4].  
The reciprocal responses of HO-1 and ALAS1 suggest an 
increase in hepatic intracellular free heme following 
LPS treatment.
Effects of LPS treatment on nuclear Bach1 protein 
expression. Bach1 is a heme-responsive transcrip-
tion factor and key regulator of HO-1 expression.  
Therefore,  we analyzed the expression of Bach1 protein 
in the nucleus.  Nuclear Bach1 protein expression 
showed a significant but transient decrease and was 
barely detectable by 1 h after LPS injection,  followed by 
a rapid return to baseline by 3 h (Fig. 4A and B).  These 
changes may reflect Bach1 nuclear export via the direct 
binding of Bach1 to the increased intracellular heme 
after LPS treatment.
Effects of LPS treatment on Bach1 expression.
Similar to hepatic HO-1 mRNA,  Bach1 mRNA expres-
sion was very low in untreated and vehicle-treated con-
trol livers (Fig. 5A and B).  Bach1 mRNA then began 
increasing immediately after LPS injection,  reaching a 
maximum level that was 5-fold higher than the level in 
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Fig. 3　 Effects of LPS treatment on HO-1 and ALAS1 gene expression.  The rats were sacrificed at 0,  1,  3,  6,  12,  24,  or 48 h after i.v.  
injection of LPS (10 mg/kg),  and their livers were excised for RNA isolation.  Total RNA (20 μg) was subjected to northern blot analysis.  
Shown are autoradiographic signals of RNA blots hybridized with [α-32P] dCTP-labeled (A) HO-1 or (C) ALAS1 cDNA probes.  Ethidium 
bromide staining of the same RNA is shown as the loading control.  Closed arrowhead,  28S ribosomal RNA; open arrowhead,  18S ribo-
somal RNA.  More than three independent experiments showed similar results,  and a typical example is shown; (B),  Concentrations of 
HO-1 mRNA are expressed as values relative to the concentration of untreated control spleens,  in which HO-1 is known to be constitu-
tively expressed; (D),  Concentrations of ALAS1 mRNA are expressed as values relative to the concentration of untreated control livers.  
HO-1,  heme oxygenase-1; ALAS1,  δ-aminolevulinate synthase; LPS,  lipopolysaccharide; NS 6 h,  vehicle-treated control; LPS 0 h,  
untreated control.
control livers at 3-6 h after LPS injection,  shortly after 
the transient decrease in nuclear Bach1 protein,  fol-
lowed by a rapid decrease to baseline levels by 24 h 
(Fig. 5A and B).  These results suggest that Bach1 mRNA 
was highly induced to compensate for the consumption 
of Bach1 protein,  which might be exported from the 
nucleus by binding to elevated intracellular heme after 
LPS treatment.
Effects of LPS and hemin treatment on nuclear 
Bach1 protein expression. Rather than directly 
detecting intracellular heme in the livers of rats injected 
with LPS,  we developed a rat model of elevated hepatic 
heme concentrations by i.v.  administration of hemin 
(50 mg/kg).  Similar to the observations in rats treated 
with LPS (Fig. 6A and B),  nuclear Bach1 protein 
decreased 1 h after hemin treatment in the liver (Fig. 6C 
and D).  These results may suggest that Bach1 protein 
was exported from the nucleus by binding to increased 
free heme and that Bach1 protein transiently disap-
peared from the nucleus.
Effects of LPS and hemin treatment on the heme 
concentration in microsomes. Additionally,  we ana-
lyzed the heme concentration in LPS-treated and 
hemin-treated livers.  The heme concentration in the 
hepatic microsomal fraction showed a significant 
increase 1 h after LPS and hemin treatment compared 
to the untreated and vehicle-treated control groups 
(Fig. 7).  These results support the idea that the heme 
concentration in hepatic tissue was elevated after both 
LPS and hemin treatment.
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Fig. 4　 Effects of LPS treatment on nuclear Bach1 protein levels.  
The rats were sacrificed at 0,  1,  3,  6,  12,  or 24 h after i.v.  injec-
tion of LPS (10 mg/kg),  and their livers were excised for nuclear 
protein extraction.  Nuclear protein (25 µg) was subjected to western 
blot analysis.  (A),  Blots of nuclear proteins were incubated with 
anti-Bach1 or anti-actin antibodies.  Blots show one representative 
example of at least three separate experiments; (B),  The intensity 
of bands of nuclear Bach1 protein was quantified by digital densi-
tometry,  normalized to actin,  and expressed in arbitrary units.  Data 
are expressed as the means±standard deviations (n=3-4) and 
were statistically evaluated by ANOVA followed by Bonferroni cor-
rection post-hoc tests.  ＊P<0.05 versus the untreated control group 
(LPS 0 h).  LPS,  lipopolysaccharide; LPS 0 h,  untreated control.
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Fig. 5　 Effects of LPS treatment on Bach1 gene expression.  The 
rats were sacrificed at 0,  1,  3,  6,  12,  24,  or 48 h after i.v.  injec-
tion of LPS (10 mg/kg),  and their livers were excised for RNA iso-
lation.  Total RNA (20 μg) was subjected to northern blot analysis.  
(A),  Representative autoradiographic signals of RNA blots hybrid-
ized with the [α-32P] dCTP-labeled Bach1 cDNA probe are shown.  
Ethidium bromide staining of the same RNA is shown as the loading 
control.  Closed arrowhead,  28S ribosomal RNA; open arrowhead,  
18S ribosomal RNA; (B),  Bach1 expression levels are given in 
densitometric arbitrary units.  More than three independent experi-
ments showed similar results,  and a typical example is shown.  
LPS,  lipopolysaccharide; NS 6 h,  vehicle-treated control; LPS 0 h,  
untreated control.
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Fig. 6　 Effects of LPS and hemin treatment on nuclear Bach1 protein expression.  The rats were sacrificed at 1 h after i.v.  injection of 
LPS (10 mg/kg) or hemin (50 mg/kg),  and their livers were excised for nuclear protein extraction.  Nuclear protein (25 μg) was subjected to 
western blot analysis to quantify nuclear Bach1 protein levels.  Blots were incubated with anti-Bach1 or anti-actin antibodies.  (A and C) 
Blots show one representative example of three independent experiments.  (B and D) The intensity of bands of nuclear Bach1 protein was 
quantified by digital densitometry,  normalized to actin,  and expressed in arbitrary units.  Data are expressed as the means±standard devi-
ations (n=3) and were statistically evaluated by ANOVA followed by Bonferroni correction post-hoc tests.  ＊P<0.05 versus the untreated 
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Fig. 7　 Effects of LPS and hemin treatment on the heme concentration in microsomes.  The rats were sacrificed at 1 h after i. v.  
injection of LPS (10 mg/kg) or hemin (50 mg/kg),  and their livers were excised for microsomal protein extraction.  Microsomal protein was 
used for the measurement of the heme concentration by the pyridine hemochromogen method.  The heme concentration was expressed as 
nanomoles per milligram of hepatic microsomal protein.  Data are expressed as the means±standard deviations (n=3-6) and were 
statistically evaluated by ANOVA followed by Bonferroni correction post-hoc tests.  ＊P<0.05 versus the untreated control group.  Control,  
untreated control; NS 1 h,  vehicle-treated control.
Discussion
In the present study,  we demonstrated that hepatic 
HO-1 mRNA expression was upregulated,  and hepatic 
ALAS-1 mRNA expression was downregulated in the 
liver in a rat model of experimental endotoxemia fol-
lowing i.v.  LPS injection.  We also demonstrated that 
nuclear Bach1 protein was transiently and significantly 
decreased after i.v.  LPS administration.  This is the first 
study showing a decline in nuclear Bach1 protein in a 
septic animal model.  The decline in Bach1 protein was 
followed by an immediate increase in hepatic Bach1 
mRNA expression.  Because HO-1 and ALAS-1 are heme 
regulatory genes and Bach1 is a heme-responsive tran-
scription factor of HO-1 expression,  these results suggest 
that increased intracellular free heme concentrations in 
the liver are involved in the pathogenesis of acute liver 
injury in LPS-treated animals.
We first evaluated changes in heme regulatory genes 
in the livers of LPS-treated rats.  Following i.v.  LPS 
treatment,  hepatic HO-1 mRNA expression was signifi-
cantly upregulated,  whereas hepatic ALAS-1 mRNA 
expression was transiently downregulated.  These results 
are consistent with those in our previous reports on 
septic liver injury after intraperitoneal administration of 
LPS (10 mg/kg) [4].  Notably,  HO-1 is upregulated and 
ALAS-1 is downregulated in the presence of excess 
heme,  a potent pro-oxidant [15].  Thus,  the reciprocal 
responses of HO-1 and ALAS1 in this study suggest an 
increase in hepatic intracellular free heme concentra-
tions following LPS treatment.
Bach1 is a heme-responsive transcription factor that 
normally represses the expression of HO-1 mRNA [5-7].  
In this study,  we demonstrated that Bach1 protein tran-
siently disappeared from the nucleus of rat liver cells 
immediately after i.v.  LPS injection.  This result indi-
cates that Bach1 protein might be exported from the 
nucleus,  likely by directly binding to increased intracel-
lular free heme released from disrupted hepatic heme 
proteins,  such as cytochrome P450.  In several in vitro 
studies,  the transcription factor Bach1 has been shown 
to be released from the promoter region of HO-1 and 
exported from the nucleus by binding to heme in the 
presence of excess free heme and oxidative stress; in 
turn,  HO-1 transcription is activated by nuclear factor 
(erythroid-derived 2)-like 2 (Nrf2) [16-18] (Fig. 8).  
Raval et al.  reported nuclear export of Bach1 protein by 
heme-mediated oxidative stress evoked by ultraviolet A 
irradiation in their cell culture study [16].  Although 
this translocation has been demonstrated in cell culture 
studies,  few reports have described these findings in 
animal models [19].
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Fig. 8　 HO-1 gene regulation by transcription factors Bach1 and Nrf2.  Diagrammatic explanation of HO-1 gene regulation under the 
normal and pro-oxidant conditions.  The heme-responsive transcription factor Bach1 normally represses expression of the HO-1 gene.  
However,  in the presence of excess free heme and oxidative stress,  several in vitro studies report that Bach1 protein is exported from the 
nucleus by binding with free heme,  after which Nrf2 protein is imported into the nucleus and the HO-1 gene expression is induced.
Following the transient decline in nuclear Bach1 
protein,  Bach1 mRNA was strongly induced in hepatic 
tissue after LPS treatment.  Additionally,  nuclear Bach1 
protein quickly returned to baseline levels.  Raval et al.  
also reported that ultraviolet A irradiation of cultured 
human skin fibroblasts enhanced Bach1 mRNA expres-
sion to control HO-1 overexpression [16].  They specu-
lated that it would be crucial to restore intracellular 
homeostasis because prolonged HO-1 overexpression is 
likely detrimental once excess free heme is catabolized 
and heme levels return to normal.  In this study,  Bach1 
was upregulated,  presumably to compensate for the 
consumption of nuclear Bach1 protein,  which had been 
exported from the nucleus by binding to elevated intra-
cellular heme.  Based on previously reported in vitro 
findings,  these results suggest that induction of Bach1 is 
important for preventing prolonged HO-1 overexpres-
sion to maintain intracellular homeostasis.
We predicted that the presence of free heme released 
from disrupted hepatic heme proteins can lead to 
nuclear export of Bach1 protein.  Although measure-
ment of the concentration of free heme is crucial for 
determining the involvement of free heme,  free heme is 
thought to be structurally unstable and technically diffi-
cult to measure accurately [20 , 21].  The concentration 
of free heme in living cells is considered to be very low,  
making it difficult to determine by existing quantitative 
methods.  Rather than quantifying free heme in hepatic 
tissue,  we administered hemin i.v.  to mimic the condi-
tions of elevated heme concentrations in hepatic tissue.  
In the presence of artificially elevated heme concentra-
tions,  nuclear Bach1 protein also declined immediately 
after hemin treatment.  Similar declines in nuclear 
Bach1 protein after both LPS and hemin treatment sug-
gested that free heme released from hepatic heme pro-
teins binds to Bach1 protein for export from the 
nucleus.
Our study had several limitations.  First,  we only 
detected a decline of nuclear Bach1 protein and we did 
not detect significant changes in cytosolic Bach1 protein 
or a significant increase in nuclear Nrf2 protein.  
Nuclear export of Bach1 and nuclear import of Nrf2 are 
thought to be essential for activating HO-1 transcription 
[16 , 17].  However,  these transcription factors are 
reported to be rapidly degraded by the ubiquitin prote-
asome pathway in the cytoplasm [22-24]; therefore,  
assessing changes in these proteins may be difficult.  
Regarding Bach1 protein,  we did not determine its sub-
cellular localization by immunostaining under either 
normal or septic conditions.  In addition,  we did not 
directly measure the concentrations of free heme in 
hepatic tissues.  As described above,  detection of free 
heme at low concentrations in biological samples is 
quite difficult [20 , 21],  and we could not find a suitable 
method.  Although we determined that the heme con-
centration in the hepatic microsomal fraction was ele-
vated in LPS-treated and hemin-treated rat livers by the 
pyridine hemochromogen method,  it is not clear whether 
these responses directly reflected the increase of free heme 
concentration in hepatic tissue.  In this study,  we pre-
dicted that the mechanism of endotoxemia-induced 
liver injury involves the release of free heme from dis-
rupted hepatic heme protein; however,  we only evalu-
ated changes in heme regulatory genes and heme-re-
sponsive transcription factor in LPS-treated and hemin- 
treated animals.  There are several reports demonstrat-
ing that free heme plays an important role in the patho-
genesis of severe sepsis,  and that hemopexin,  a plasma 
protein that binds heme with extraordinary affinity,  
suppresses the cytotoxic effects of free heme,  suggest-
ing that targeting free heme may be useful for the treat-
ment of severe sepsis [25].
In conclusion,  we demonstrated that the transcrip-
tion factor Bach1 disappeared from the nucleus of liver 
cells in an experimental endotoxemia rat model.  We 
also directly demonstrated that nuclear Bach1 protein 
declined in a similar manner in the presence of elevated 
heme concentrations.
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